Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account
Roberta Vitale, Stefania Marzocco, Ada Popolo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7477-7477
Open Access | Times Cited: 12

Showing 12 citing articles:

Inhibition of NETs prevents doxorubicin-induced cardiotoxicity by attenuating IL-18-IFN-γ-Cx43 axis induced cardiac conduction abnormalities
Kun Li, Kunmao Jiang, Yu Wang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114016-114016
Closed Access | Times Cited: 1
Managing Doxorubicin Cardiotoxicity: Insights Into Molecular Mechanisms and Protective Strategies
Adnan Taan Al khafaji, Ali Barakat, Akram Joudah shayyal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access | Times Cited: 1
Sauchinone Preserves Cardiac Function in Doxorubicin-Induced Cardiomyopathy by Inhibiting the NLRP3 Inflammasome
Wei Xin, Xiangliang Yang, Xinyu Heng, et al.
Phytomedicine (2025) Vol. 140, pp. 156624-156624
Open Access | Times Cited: 1
Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity
Chinmay Pal
Cardiovascular Toxicology (2024)
Closed Access | Times Cited: 4
Buthionine sulfoximine acts synergistically with doxorubicin as a sensitizer molecule on different tumor cell lines
Joedna Cavalcante Pereira, Rayran Walter Ramos de Sousa, Micaely Lorrana Pereira Conceição, et al.
Journal of Toxicology and Environmental Health (2025), pp. 1-23
Closed Access
THE ROLE OF MATRIX METALLOPROTEINASE-9 AS A BIOLOGICAL MARKER IN HEART FAILURE
Albina B. Sultangalieva, Amina M. Alieva, Alik M. Rakhaev, et al.
Russian Medicine (2025)
Closed Access
Inhibition of GRK2 reduced doxorubicin-induced oxidative stress and apoptosis through upregulating ADH1
Zihao Jiang, Junyan Kan, Dongchen Wang, et al.
Toxicology and Applied Pharmacology (2025), pp. 117261-117261
Closed Access
Inhibition of HSC proliferation and hepatic fibrogenesis with Erythrocyte membrane coated Doxorubicin/Black phosphorus nanosheets
Xiang Li, Xianjing Xiang, Qiangqiang Jiao, et al.
International Journal of Pharmaceutics (2025) Vol. 673, pp. 125403-125403
Closed Access
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
ROS-mediated ferroptosis and pyroptosis in cardiomyocytes: An update
Tao Li, Ningning Wang, Dan Yi, et al.
Life Sciences (2025), pp. 123565-123565
Closed Access
NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals
Xiaopeng Zhao, Lian Duan, Qianru Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Prooxidant state in anticancer drugs and prospect use of mitochondrial cofactors and anti-inflammatory agents in cancer prevention
Giovanni Pagano, Alex Lyakhovich, Philippe J. Thomas, et al.
Inflammopharmacology (2024)
Closed Access
Page 1

Scroll to top